PAHC logo

Phibro Animal Health (PAHC)

Profile

Full Name

Phibro Animal Health Corporation

Ticker Symbol

PAHC

Exchange

NASDAQ

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

United States

IPO

April 11, 2014

Indexes

Not included

Website

http://www.pahc.com

Employees

1940

Key Details

Price

$19.06(+6.60%)

Market cap

$772.00M(Small cap)

Last Dividend

$0.12

TTM Dividend yield

2.52%

Annual revenue

$1.02B(+4.07% YoY)

Annual EPS

$0.06(-92.59% YoY)

PE ratio

39.71

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$19.06
PAHC price is $19.06

30-Day Relative Volume

1.09
PAHC 30-day relative volume is 1.09

Price Performance

Price Most recent change

+6.6%
PAHC price was up +6.6% on Apr 9, 2025

Price YTD change

-9.24%
PAHC price is down -9.24% since January 1st

Price 1-year change

+45.27%
PAHC price is up +45.27% year-on-year

Price 3-year change

-0.99%
PAHC price is down -0.99% over the past 3 years

Price Range

Price All-time high

$54.62
PAHC price is currently -65.10% below its historical high of $54.62

Price 3-year low

$9.40
PAHC price is currently +102.77% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$772.00M
PAHC market capitalization is $772.00 million

Market cap 3-year change

-0.99%
PAHC market capitalization is down -0.99% over the past 3 years

Market cap All-time high

$2.16B
PAHC market capitalization is currently -64.25% below its historical high of $2.16 billion

Market cap sector rank

74.2%
PAHC market capitalization is higher than 74.2% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

0%
PAHC {parameterFullLabel} has remained unchanged year-on-year

Shares Outstanding 3-Year Change

0%
PAHC {parameterFullLabel} has remained unchanged over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.05
PAHC beta is 1.05

200-day SMA

$21.41
PAHC price is currently -10.99% below its 200-day simple moving average

50-day SMA

$22.43
PAHC price is currently -15.01% below its 50-day simple moving average

RSI

36.71
PAHC 14-day relative strength index is 36.71

Volume

1.09
PAHC 30-day relative volume is 1.09

ATR

$1.16
PAHC average true range is $1.16

10-day Historical Volatility

64.56%
PAHC 10-day historical volatility is 64.56%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.12
PAHC last dividend was $0.12 per share, with an ex-dividend date of March 5, 2025

Next Dividend

-
PAHC next dividend has not yet been announced

Dividend per share

Dividend per share

$0.48
PAHC annual dividend per share is $0.48

Dividend per share Sector Rank

20.93%
PAHC annual dividend per share is higher than 20.93% of companies in Healthcare sector

Dividend per share 1-Year Change

0%
PAHC {parameterFullLabel} has remained unchanged year-on-year

Dividend per share 3-Year Change

0%
PAHC {parameterFullLabel} has remained unchanged over the past 3 years

Dividend yield

Dividend yield

2.52%
PAHC annual dividend yield is 2.52%

Dividend yield Sector Rank

54.12%
PAHC annual dividend yield is higher than 54.12% of companies in Healthcare sector

Other

Payout ratio

804.72%
PAHC annual payout ratio is 804.72%

Dividends paid

$19.44M
PAHC annual dividends paid is $19.44 million

Free cash flow

$46.36M
PAHC annual free cash flow is $46.36 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.02B
PAHC annual revenue is $1.02 billion

Revenue Analysts estimate

$1.28B
PAHC annual revenue is currently -20.56% lower than the consensus analysts' forecast

Revenue 1-year change

+4.07%
PAHC annual revenue is up +4.07% year-on-year

Revenue Sector rank

80.54%
PAHC annual revenue is higher than 80.54% of companies in Healthcare sector

EPS

EPS

$0.06
PAHC annual earnings per share is $0.06

EPS Analysts estimate

$1.95
PAHC annual earnings per share is currently -96.93% lower than the consensus analysts' forecast

EPS 1-year change

-92.59%
PAHC annual earnings per share is down -92.59% year-on-year

EPS Sector rank

83.06%
PAHC annual earnings per share is higher than 83.06% of companies in Healthcare sector

Profit

Gross profit

$313.09M
PAHC annual gross profit is $313.09 million

Gross margin

30.77%
PAHC annual gross profit margin is 30.77%

Operating profit

$53.31M
PAHC annual operating income is $53.31 million

Operating margin

5.24%
PAHC annual operating profit margin is 5.24%

Net income

$2.42M
PAHC annual net profit is $2.42 million

Net margin

0.24%
PAHC annual net profit margin is 0.24%

Expenses

Total expenses

$964.36M
PAHC annual total expenses is $964.36 million

Operating expenses

$259.78M
PAHC annual total operating expenses is $259.78 million

Cost of goods sold

$704.59M
PAHC annual cost of goods sold is $704.59 million

Selling, general & administrative expenses

$259.78M
PAHC annual SGA is $259.78 million

Depreciation and amortization

$36.18M
PAHC annual depreciation & amortization is $36.18 million

Interest expense

$21.97M
PAHC annual interest expense is $21.97 million

Income tax

$8.50M
PAHC annual income tax is $8.50 million

EBIT & EBITDA

EBIT

$32.89M
PAHC annual earnings before interest & taxes is $32.89 million

EBITDA

$69.06M
PAHC annual EBITDA is $69.06 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$982.18M
PAHC annual total assets is $982.18 million

Non current assets

$381.19M
PAHC annual long term assets is $381.19 million

Current assets

$601.00M
PAHC annual total current assets is $601.00 million

Cash and cash equivalents

$70.61M
PAHC annual cash & cash equivalents is $70.61 million

Accounts receivable

$169.45M
PAHC annual accounts receivable is $169.45 million

Inventory

$265.91M
PAHC annual inventory is $265.91 million

Liabilities

Total liabilities

$725.54M
PAHC annual total liabilities is $725.54 million

Long term liabilities

$521.39M
PAHC annual total long term liabilities is $521.39 million

Current liabilities

$204.15M
PAHC annual total current liabilities is $204.15 million

Accounts payable

$85.57M
PAHC annual accounts payable is $85.57 million

Debt

Total debt

$525.46M
PAHC annual total debt is $525.46 million

Total debt 1-year change

+3.04%
PAHC annual total debt is up +3.04% year-on-year

Long term debt

$488.20M
PAHC annual long term debt is $488.20 million

Short term debt

$37.26M
PAHC annual short term debt is $37.26 million

Equity & Capital

Shareholders equity

$256.64M
PAHC annual stockholders equity is $256.64 million

Book value

$256.64M
PAHC annual book value is $256.64 million

Retained earnings

$243.89M
PAHC annual retained earnings is $243.89 million

Working capital

$396.85M
PAHC annual working capital is $396.85 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$87.59M
PAHC annual cash flow from operations is $87.59 million

Cash from operations 1-year change

+558.11%
PAHC annual cash flow from operations is up +558.11% year-on-year

Cash from investing

-$48.19M
PAHC annual cash flow from investing activities is -$48.19 million

Cash from investing 1-year change

+34.89%
PAHC annual cash flow from investing activities is up +34.89% year-on-year

Cash from financing

-$6.77M
PAHC annual cash flow from financing activities is -$6.77 million

Cash from financing 1-year change

-125.08%
PAHC annual cash flow from financing activities is down -125.08% year-on-year

CAPEX

CAPEX

$41.24M
PAHC annual capital expenditures is $41.24 million

CAPEX 1-year change

-20.38%
PAHC annual capital expenditures is down -20.38% year-on-year

Free Cash Flow

Free cash flow

$46.36M
PAHC annual free cash flow is $46.36 million

Free cash flow 1-year change

+220.46%
PAHC annual free cash flow is up +220.46% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

30.77%
PAHC annual gross profit margin is 30.77%

Operating margin

5.24%
PAHC annual operating profit margin is 5.24%

Net margin

0.24%
PAHC annual net profit margin is 0.24%

ROA & ROE

ROA

0.25%
PAHC annual return on assets is 0.25%

ROE

0.90%
PAHC annual return on equity is 0.90%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

39.71
PAHC price to earnings ratio is 39.71

PE ratio Sector rank

73.04%
PAHC price to earnings ratio is higher than 73.04% of companies in Healthcare sector

PB Ratio

PB ratio

3.13
PAHC price to book ratio is 3.13

PB ratio Sector rank

73.52%
PAHC price to book ratio is higher than 73.52% of companies in Healthcare sector

PS Ratio

PS ratio

0.70
PAHC price to sales ratio is 0.70

PS ratio Sector rank

21.54%
PAHC price to sales ratio is higher than 21.54% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.49B
PAHC enterprise value is $1.49 billion

Enterprise value Sector rank

79.06%
PAHC enterprise value is higher than 79.06% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

14.76
PAHC EV/EBITDA is 14.76

EV/EBITDA Sector rank

87.5%
PAHC EV/EBITDA is higher than 87.5% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.94
PAHC annual current ratio is 2.94

Quick ratio

1.64
PAHC annual quick ratio is 1.64

Leverage

Debt to equity

1.90
PAHC annual debt to equity ratio is 1.90

Interest coverage ratio

1.50
PAHC annual interest coverage ratio is 1.50

Risk & Stability

Piotroski F-Score

8
PAHC piotroski f-score is 8

Altman Z-Score

2.62
PAHC altman z-score is 2.62

Analyst ratings

Recent major analysts updates

Feb 10, 25 Barclays
Underweight
Dec 17, 24 Morgan Stanley
Equal-Weight
Nov 12, 24 Barclays
Underweight
Sep 10, 24 JP Morgan
Neutral
Aug 30, 24 B of A Securities
Underperform
May 10, 24 Barclays
Underweight
Nov 9, 23 Morgan Stanley
Equal-Weight
Sep 1, 23 Roth MKM
Buy
Aug 31, 23 Morgan Stanley
Equal-Weight
Aug 29, 23 Roth MKM
Buy

Institutional Ownership

Similar stocks

MYGN logo
Myriad Genetics (MYGN)
WEAV logo
Weave Communications (WEAV)
OCS logo
Oculis Holding AG (OCS)
STAA logo
STAAR Surgical (STAA)
VIR logo
Vir Biotechnology (VIR)
AMN logo
AMN Healthcare Services (AMN)
CMRX logo
Chimerix (CMRX)
AXGN logo
AxoGen (AXGN)
AVXL logo
Anavex Life Sciences (AVXL)
  • What is the ticker symbol for Phibro Animal Health?
  • Does Phibro Animal Health pay dividends?
  • What sector is Phibro Animal Health in?
  • What industry is Phibro Animal Health in?
  • What country is Phibro Animal Health based in?
  • When did Phibro Animal Health go public?
  • Is Phibro Animal Health in the S&P 500?
  • Is Phibro Animal Health in the NASDAQ 100?
  • Is Phibro Animal Health in the Dow Jones?
  • When was Phibro Animal Health's last earnings report?
  • When does Phibro Animal Health report earnings?
  • Should I buy Phibro Animal Health stock now?

What is the ticker symbol for Phibro Animal Health?

The ticker symbol for Phibro Animal Health is NASDAQ:PAHC

Does Phibro Animal Health pay dividends?

Yes, Phibro Animal Health pays dividends. The last payment was $0.12, with an ex-dividend date on March 5, 2025

What sector is Phibro Animal Health in?

Phibro Animal Health is in the Healthcare sector

What industry is Phibro Animal Health in?

Phibro Animal Health is in the Drug Manufacturers - Specialty & Generic industry

What country is Phibro Animal Health based in?

Phibro Animal Health is headquartered in United States

When did Phibro Animal Health go public?

Phibro Animal Health's initial public offering (IPO) was on April 11, 2014

Is Phibro Animal Health in the S&P 500?

No, Phibro Animal Health is not included in the S&P 500 index

Is Phibro Animal Health in the NASDAQ 100?

No, Phibro Animal Health is not included in the NASDAQ 100 index

Is Phibro Animal Health in the Dow Jones?

No, Phibro Animal Health is not included in the Dow Jones index

When was Phibro Animal Health's last earnings report?

Phibro Animal Health's most recent earnings report was on Feb 5, 2025

When does Phibro Animal Health report earnings?

The next expected earnings date for Phibro Animal Health is May 9, 2025

Should I buy Phibro Animal Health stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page